£495.00

The 2023-2028 Outlook for Beta Interferon Therapeutics for Multiple Sclerosis in Japan

Subjects

Price data updated today

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£495 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 91 days • 91 data points

Historical

Generating forecast...

Price Distribution

Price distribution over 91 days • 1 price levels

Days at Price

Price Analysis

Most common price: £495 (91 days, 100.0%)

Price range: £495 - £495

Price levels: 1 different prices over 91 days

Product Specifications

Format: paperback
ASIN: B0BP9JNZJ6
Category: Books > Subjects
Domain: Amazon UK
Release Date: 28 November 2022
Listed Since: 07 December 2022

The 2023-2028 Outlook for Beta Interferon Therapeutics for Multiple Sclerosis in Japan

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Product Specifications

Similar Products You Might Like

The 2023-2028 Outlook for Beta Interferon Therapeutics for Multiple Sclerosis in India

The 2023-2028 Outlook for Beta Interferon Therapeutics for Multiple Sclerosis in the United States

The 2023-2028 Outlook for Beta Interferon Therapeutics for Multiple Sclerosis for US Zip Codes

The 2025-2030 World Outlook for Beta Interferon Therapeutics for Multiple Sclerosis

The 2016-2021 Outlook for Multiple Sclerosis Therapeutics in the United States

The 2023 Report on Multiple Sclerosis Therapeutics: World Market Segmentation by City

The 2016 Report on Multiple Sclerosis Therapeutics: World Market Segmentation by City

The 2023 Report on Multiple Sclerosis Treatments: World Market Segmentation by City

Multiple Sclerosis - Pathways, Diagnosis and Therapeutic Targets (Nervous System and Mental Health)

The 2023-2028 Outlook for Multiple Myeloma Therapeutics in Japan

The 2013-2018 Outlook for Multiple Myeloma Therapeutics in Africa

Multiple Sclerosis in Children and Adolescents - Medical Book

Multiple Sclerosis - Genetics, Disease Mechanisms and Clinical Developments

Living with Multiple Sclerosis: A Group-Based Psychological Support Intervention for Newly Diagnosed People with MS (LiMS)

Translational Methods for Multiple Sclerosis Research: 166 (Neuromethods, 166)

Translational Methods for Multiple Sclerosis Research: 166 (Neuromethods, 166)

Clinical Aspects of Multiple Sclerosis Essentials and Current Updates

The 2023-2028 Outlook for Multiple Myeloma Treatments in Japan

The 2023-2028 Outlook for Multiple Myeloma Treatments in China

The 2023-2028 Outlook for Advanced Therapy Medicinal Products in Japan

The 2023-2028 Outlook for Peripheral Neuritis Treatments in China

Multiple Sclerosis

The 2023-2028 Outlook for Peripheral Neuritis Treatments in India

Neuroreha bei Multipler Sklerose: Therapie - Sport - Selbsthilfe